Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD	Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis	Enrolling by invitation	Phase 2	2026-10-06		NCT07652294

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Spyre Therapeutics, Inc.	5

69 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Site 007	Kissimmee	United States	2
Site 012	Lancaster	United States	2
Site 019	Tacoma	United States	2
Site 025	Providence	United States	2
Site 035	Marrero	United States	2
Site 103	Rosario	Argentina	1
Site 206	South Brisbane	Australia	1
Site 208	Concord	Australia	1
Site 353	Wŏnju	South Korea	1
Site 354	Daegu	South Korea	1
Site 355	Daejeon	South Korea	2
Site 356	Seoul	South Korea	2
Site 357	Busan	South Korea	2
Site 361	Daegu	South Korea	2
Site 391	Taipei	Taiwan	2
Site 392	Chiayi City	Taiwan	2
Site 394	Changhua	Taiwan	2
Site 396	Taichung	Taiwan	2
Site 422	Irbid	Jordan	2
Site 423	Irbid	Jordan	2
Site 424	Amman	Jordan	2
Site 471	Ghent	Belgium	1
Site 531	Brno	Czechia	2
Site 581	Tbilisi	Georgia	2
Site 582	Tbilisi	Georgia	2

Clinical trials